137 related articles for article (PubMed ID: 7459239)
1. Oestrogen-receptor status and endocrine therapy of breast cancer: response rates and status stability.
Leake RE; Laing L; Calman KC; Macbeth FR; Crawford D; Smith DC
Br J Cancer; 1981 Jan; 43(1):59-66. PubMed ID: 7459239
[TBL] [Abstract][Full Text] [Related]
2. Soluble and nuclear oestrogen receptor status in human breast cancer in relation to prognosis.
Leake RE; Laing L; McArdle C; Smith DC
Br J Cancer; 1981 Jan; 43(1):67-71. PubMed ID: 7459240
[TBL] [Abstract][Full Text] [Related]
3. Expression of the oestrogen regulated pNR-2 mRNA in human breast cancer: relation to oestrogen receptor mRNA levels and response to tamoxifen therapy.
Henry JA; Nicholson S; Hennessy C; Lennard TW; May FE; Westley BR
Br J Cancer; 1990 Jan; 61(1):32-8. PubMed ID: 2153395
[TBL] [Abstract][Full Text] [Related]
4. Activated oestrogen receptors in breast cancer and response to endocrine therapy.
Fernandez MD; Burn JI; Sauven PD; Parmar G; White JO; Myatt L
Eur J Cancer Clin Oncol; 1984 Jan; 20(1):41-6. PubMed ID: 6537914
[TBL] [Abstract][Full Text] [Related]
5. The prediction of hormonal dependency of mammary cancer.
Block GE; Jensen EV; Polley TZ
Ann Surg; 1975 Sep; 182(3):342-52. PubMed ID: 169754
[TBL] [Abstract][Full Text] [Related]
6. Estrogen receptors and breast cancer: prognostic and therapeutic implications.
Gapinski PV; Donegan WL
Surgery; 1980 Sep; 88(3):386-93. PubMed ID: 7414516
[TBL] [Abstract][Full Text] [Related]
7. Quantitative oestradiol receptor values in primary breast cancer and response of metastases to endocrine therapy.
Campbell FC; Blamey RW; Elston CW; Morris AH; Nicholson RI; Griffiths K; Haybittle JL
Lancet; 1981 Dec; 2(8259):1317-9. PubMed ID: 6118718
[TBL] [Abstract][Full Text] [Related]
8. DNA/protein ratio as an index of oestrogen receptor content in human breast cancer.
Muñoz J; Bolufer P; Rodriguez A; Antonio P; Vazquez C
Eur J Cancer Clin Oncol; 1983 Sep; 19(9):1207-12. PubMed ID: 6684567
[TBL] [Abstract][Full Text] [Related]
9. The value of determination of nuclear oestrogen receptors in breast cancer biopsies.
Cowan S; Love C; Leake RE
Recent Results Cancer Res; 1984; 91():50-60. PubMed ID: 6729228
[No Abstract] [Full Text] [Related]
10. Distribution, frequency, and quantitative analysis of estrogen, progesterone, androgen, and glucocorticoid receptors in human breast cancer.
Allegra JC; Lippman ME; Thompson EB; Simon R; Barlock A; Green L; Huff KK; Do HM; Aitken SC
Cancer Res; 1979 May; 39(5):1447-54. PubMed ID: 427788
[TBL] [Abstract][Full Text] [Related]
11. Clinical applications of receptor measurements in breast cancer.
Holdaway IM; Mountjoy KG; Harvey VJ; Allen EP; Stephens EJ
Br J Cancer; 1980 Jan; 41(1):136-9. PubMed ID: 7362774
[TBL] [Abstract][Full Text] [Related]
12. Clinical predictive criteria for response to endocrine treatment and the receptor status.
Maass H; Jonat W
Recent Results Cancer Res; 1980; 71():26-9. PubMed ID: 7378140
[TBL] [Abstract][Full Text] [Related]
13. Risk factors and clinical data related to oestrogen receptor status in women presenting with breast cancer.
Montgomery AC; McClelland RA; Skilton RA; Easton D
Br J Surg; 1985 Aug; 72(8):629-33. PubMed ID: 4027537
[TBL] [Abstract][Full Text] [Related]
14. Histological detection of oestrogen receptor in human breast carcinomas.
Walker RA; Cove DH; Howell A
Lancet; 1980 Jan; 1(8161):171-3. PubMed ID: 6153438
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneity of soluble and nuclear oestrogen receptor status of involved nodes in relation to primary breast cancer.
Castagnetta L; Traina A; Di Carlo A; Latteri AM; Carruba G; Leake RE
Eur J Cancer Clin Oncol; 1987 Jan; 23(1):31-5. PubMed ID: 3595683
[TBL] [Abstract][Full Text] [Related]
16. Breast cancer prognosis in three different racial groups in relation to steroid hormone receptor status.
Pegoraro RJ; Nirmul D; Reinach SG; Jordaan JP; Joubert SM
Breast Cancer Res Treat; 1986; 7(2):111-8. PubMed ID: 3719113
[TBL] [Abstract][Full Text] [Related]
17. Loss of estrogen receptor in recurrent breast cancer is associated with poor response to endocrine therapy.
Kuukasjärvi T; Kononen J; Helin H; Holli K; Isola J
J Clin Oncol; 1996 Sep; 14(9):2584-9. PubMed ID: 8823339
[TBL] [Abstract][Full Text] [Related]
18. Expression of ras p21, p53 and c-erbB-2 in advanced breast cancer and response to first line hormonal therapy.
Archer SG; Eliopoulos A; Spandidos D; Barnes D; Ellis IO; Blamey RW; Nicholson RI; Robertson JF
Br J Cancer; 1995 Nov; 72(5):1259-66. PubMed ID: 7577479
[TBL] [Abstract][Full Text] [Related]
19. The prognosis of breast cancer patients in relation to the oestrogen receptor status of both primary disease and involved nodes.
Castagnetta L; Traina A; Carruba G; Fecarotta E; Palazzotto G; Leake R
Br J Cancer; 1992 Jul; 66(1):167-70. PubMed ID: 1637667
[TBL] [Abstract][Full Text] [Related]
20. Triple hormone-receptor assay: a more accurate predictive tool for the treatment of advanced breast cancer?
Barnes DM; Skinner LG; Ribeiro GG
Br J Cancer; 1979 Dec; 40(6):862-5. PubMed ID: 230853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
